Celine’s technology platform integrates proprietary control modality, synthetic biology, and de novo protein designs with the power of generative AI to precisely design and deliver targeted immune-mediated therapies to the right place in the body. We are pioneering a unique approach to activate right therapy at the right place, expand targetable landscape, and automate the patient-tailored discovery process to improve safety and efficacy.